Menu
GWAS Study

GWAS Identifies Two Novel Colorectal Cancer Loci at 16q24.1 and 20q13.12.

Tanikawa C, Kamatani Y, Takahashi A et al.

29471430 PubMed ID
GWAS Study Type
44916 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TC
Tanikawa C
KY
Kamatani Y
TA
Takahashi A
MY
Momozawa Y
LK
Leveque K
NS
Nagayama S
MK
Mimori K
MM
Mori M
IH
Ishii H
IJ
Inazawa J
YJ
Yasuda J
TA
Tsuboi A
SA
Shimizu A
SM
Sasaki M
YT
Yamaji T
SN
Sawada N
IM
Iwasaki M
TS
Tsugane S
NM
Naito M
WK
Wakai K
KT
Koyama T
TT
Takezaki T
YK
Yuji K
MY
Murakami Y
NY
Nakamura Y
KM
Kubo M
MK
Matsuda K
Chapter II

Abstract

Summary of the research findings

Colorectal cancer (CRC) is the fourth leading cause of cancer mortality worldwide. Genome-wide association studies (GWAS) identified more than 50 CRC loci. However, most of the previous studies were conducted in European population, and host genetic factors among Japanese population are largely remained to be identified. To identify novel loci in the Japanese population, here, we performed a large-scale GWAS using 6692 cases and 27 178 controls followed by a replication analysis using more than 11 000 case-control samples. We found the significant association of 10 loci (P < 5 × 10-8), including 2 novel loci on 16q24.1 (IRF8-FOXF1, rs847208, P = 3.15 × 10-9 and odds ratio = 1.107 with 95% confidence interval (CI) of 1.071-1.145) and 20q13.12 (TOX2, rs6065668, P = 4.47 × 10-11 and odds ratio = 0.897 with 95% CI of 0.868-0.926). Moreover, 35 previously reported single nucleotide polymorphisms (SNPs) in 24 regions were validated in the Japanese population (P < 0.05) with the same risk allele as in the previous studies. SNP rs6065668 was significantly associated with TOX2 expression in the sigmoid colon. In addition, nucleotide substitutions in the regulatory region of TOX2 were predicted to alter the binding of several transcription factors, including KLF5. Our findings elucidate the important role of genetic variations in the development of CRC in the Japanese population.

6,692 Japanese ancestry cases, 27,178 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

44916
Total Participants
GWAS
Study Type
Yes
Replicated
3,713 Japanese ancestry cases, 7,333 Japanese ancestry controls
Replication Participants
East Asian
Ancestry
Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.